A recent investigation published in Cannabis reveals that the nature of attention-deficit/hyperactivity disorder (ADHD) symptoms—specifically inattention versus hyperactivity-impulsivity—predicts different patterns of cannabis-related consequences among young adult users.
Study Design and Participant Profile
Researchers from York University and collaborating institutions surveyed 160 cannabis-using young adults in Toronto, aged 19 to 25, distinguishing between those with inattentive (IN) and hyperactive-impulsive (HI) ADHD symptoms. Participants completed structured clinical interviews for cannabis use disorder (CUD), self-reported their ADHD symptoms, and described cannabis-related consequences across multiple domains—ranging from academic and self-care issues to physical dependence and memory lapses. Quantity of cannabis used over the prior 90 days was also recorded.
Key Findings
- Individuals with inattention-dominant symptoms experienced heightened negative outcomes—including academic or occupational difficulties, poor self-care, and memory or blackout episodes—that were independent of how much cannabis they consumed.
- In contrast, those with hyperactive-impulsive symptoms did not show a direct relationship with these consequences. Instead, their symptoms were correlated with higher cannabis intake, which in turn predicted greater risks of physical dependence, impaired control, and CUD—suggesting an indirect, consumption-mediated pathway.
- Intriguingly, when controlling for the overlap between symptom types, inattention symptoms were linked to fewer risks of dependence and impaired control—an unexpected suppression effect that underlines the complexity of how ADHD symptom domains interact.
Implications and Expert Insight
These results underscore the importance of differentiating ADHD symptom subtypes when evaluating cannabis-related harm in young adults. Inattention may predispose individuals to functional struggles—especially in memory and daily responsibilities—regardless of usage levels. Conversely, hyperactivity-impulsivity may elevate the risk for dependency, but largely through greater consumption behaviors.
Jeffrey Wardell, one of the study authors, noted that while individuals with ADHD may perceive cannabis as palliative—particularly those with hyperactive symptoms—there remain significant risks of adverse outcomes even if usage feels subjectively beneficial.
Cautions and Future Research Needs
The study’s cross-sectional design prevents firm causal conclusions. It remains undetermined whether ADHD symptoms promote cannabis-related issues, or if cannabis use exacerbates ADHD-like symptoms over time. The authors recommend longitudinal studies and tailored clinical assessments accounting for ADHD symptom domains to better inform intervention strategies.
Dabbin-Dad Newsroom
